seed
Stage
1
Investors
About
ToxoTech develops engineered botulinum neurotoxin therapeutics aimed at providing more precise and durable treatments for neuromuscular and neurological disorders.
Explore ToxoTech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.